eisai.mediaroom.com
Eisai Newsroom - NewsroomEisai Newsroom
http://eisai.mediaroom.com/
Eisai Newsroom
http://eisai.mediaroom.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.6 seconds
PAGES IN
THIS WEBSITE
2
SSL
EXTERNAL LINKS
35
SITE IP
64.78.159.10
LOAD TIME
0.578 sec
SCORE
6.2
Eisai Newsroom - Newsroom | eisai.mediaroom.com Reviews
https://eisai.mediaroom.com
Eisai Newsroom
Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan - Jul 30, 2015
http://eisai.mediaroom.com/2015-07-30-Eisai-Submits-Simultaneous-Regulatory-Applications-for-Eribulin-in-Soft-Tissue-Sarcoma-in-the-United-States-European-Union-and-Japan
Eisai Co., Ltd. (Japanese). Caring to Help Others Manual. Environment, Health and Safety. Rabeprazole sodium) Delayed-Release Tablets. Get News Alerts by Email. Get News Alerts by Email. Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan. Jul 30, 2015. WOODCLIFF LAKE, N.J. July 30, 2015. Eisai Inc. announced today that regulatory applications were submitted simultaneously in the United States. European Union and Japan.
Eisai Newsroom - Newsroom
http://eisai.mediaroom.com/index.php
Eisai Co., Ltd. (Japanese). Caring to Help Others Manual. Environment, Health and Safety. Rabeprazole sodium) Delayed-Release Tablets. Get News Alerts by Email. Get News Alerts by Email. Welcome to Eisais Newsroom, an online resource for members of the media and the investment community. For investor relations inquiries, please contact:. Vice President, Commercial Development. To view Eisai Co., Ltd.s annual report, financial disclosure presentations, and other information, please click here. Oct 31, 2016.
TOTAL PAGES IN THIS WEBSITE
2
Site Map | Eisai Inc.
http://us.eisai.com/sitemap
Eisai Co., Ltd. (Japanese). Community Involvement and Advocacy Support. Access to Investigational Drugs. Environment, Health and Safety. Rabeprazole sodium) Delayed-Release Tablets. Community Involvement and Advocacy Support. Corporate Citizenship - Payments to Physicians. Access to Investigational Drugs. Environment, Health and Safety. Rabeprazole sodium) Delayed-Release Tablets. Intern, Finance and Accounting.
Vision and Values | Eisai Inc.
http://us.eisai.com/about-eisai-inc/vision-and-values
Eisai Co., Ltd. (Japanese). Community Involvement and Advocacy Support. Access to Investigational Drugs. Environment, Health and Safety. Rabeprazole sodium) Delayed-Release Tablets. Community Involvement and Advocacy Support. Access to Investigational Drugs. Environment, Health and Safety. Eisai employees believe the following five values are integral to realizing our. Mission and achieving our vision:. Honest, straightforward, open exchange of information. Pursuing excellence in all day-to-day activities.
Industry Practices | Eisai Inc.
http://us.eisai.com/about-eisai-inc/industry-practices
Eisai Co., Ltd. (Japanese). Community Involvement and Advocacy Support. Access to Investigational Drugs. Environment, Health and Safety. Rabeprazole sodium) Delayed-Release Tablets. Community Involvement and Advocacy Support. Access to Investigational Drugs. Environment, Health and Safety. The activities of Eisai Inc. in the United States are guided by our. Http:/ www.phrma.org. Http:/ oig.hhs.gov. Eisai Inc. supports the PhRMA Direct-to-Consumer (DTC) advertising recommendations as part of its commi...
Parent Company | Eisai Inc.
http://us.eisai.com/about-eisai-inc/parent-company
Eisai Co., Ltd. (Japanese). Community Involvement and Advocacy Support. Access to Investigational Drugs. Environment, Health and Safety. Rabeprazole sodium) Delayed-Release Tablets. Community Involvement and Advocacy Support. Access to Investigational Drugs. Environment, Health and Safety. The parent company of Eisai Inc. is Eisai Co., Ltd. This is the website of Eisai Inc., a US company. This site is intended for US residents only. The health information contained herein is provided for educ...Please no...
PANRETIN® | Eisai Inc.
http://us.eisai.com/our-products/panretinsup-sup
Eisai Co., Ltd. (Japanese). Community Involvement and Advocacy Support. Access to Investigational Drugs. Environment, Health and Safety. Rabeprazole sodium) Delayed-Release Tablets. Rabeprazole sodium) Delayed-Release Tablets. Alitretinoin) gel 0.1%. For more information about Panretin gel call Eisai Medical Information at. 888-274-2378. To report suspected adverse reactions, call 888-273-2378. Please see the Panretin Gel Full Prescribing Information. Panretin is a registered trademark of Eisai Inc.
Corporate Responsibility | Eisai Inc.
http://us.eisai.com/about-eisai-inc/corporate-responsibility
Eisai Co., Ltd. (Japanese). Community Involvement and Advocacy Support. Access to Investigational Drugs. Environment, Health and Safety. Rabeprazole sodium) Delayed-Release Tablets. Community Involvement and Advocacy Support. Corporate Citizenship - Payments to Physicians. Access to Investigational Drugs. Environment, Health and Safety. Ethics and Compliance Program. Our ethics and compliance program is founded on Eisai's. Human health care (hhc). For all its affiliates throughout the world. The responsi...
TOTAL LINKS TO THIS WEBSITE
35
EISAI SAS
5/6 place de l’Iris. Tél 33 (0)1 47 67 00 05. Fax 33 (0)1 47 67 00 15. Filiale française de Eisai Europe Ltd. Transparence des liens en application. Du décret n 2013-414 du 21 mai 2013. Cancer du sein métastatique. Douleur - Critical Care. 33 (0)1 47 67 12 30. 33 (0)1 47 67 12 88. 33 (0)1 47 67. Loi informatique et libertés.
EISAI Italia | human health care
EISAI Italia human health care. Prendersi cura della salute:. La ricerca farmaceutica al servizio di tutti. Una selezione delle ultime notizie da parte di Eisai, per conoscere novità, informazioni e comunicazioni. La nostra ricerca rinnova ogni giorno una grande sfida impegnandosi in soluzioni terapeutiche innovative, destinate a raggiungere milioni di persone in tutto il mondo. Trasparenza dei trasferimenti di valore. Prendersi cura della salute:. La ricerca farmaceutica al servizio di tutti.
病気の予防・治療からくすりまで見つかる | エーザイの一般生活者向けサイト | Eisai.jp
セルフケア製品広告ギャラリー にチョコラBBプラスの新TVCM 効いてよチョコラ 篇 を掲載いたしました。 セルフケア製品広告ギャラリー にチョコラBBローヤル2の新TVCM GOODチョコラMORNING 篇を掲載いたしました。 疾患啓発広告ギャラリー にTV広告 認知症の合図 篇 30秒 を掲載いたしました。
Eisai's Home Page
Welcom to Eisai's Homepage. 平成21年4月16日 ダルメシアン子犬 出産 Baby of Dalmatian April 2009. 仏教巡礼 Pilgrimage of Buddhism. 海外旅行記集 欧米編 Western countries. 著作 デザイン Eisai Ishibushi.
Eisai Newsroom - Newsroom
Eisai Co., Ltd. (Japanese). Caring to Help Others Manual. Environment, Health and Safety. Rabeprazole sodium) Delayed-Release Tablets. Welcome to Eisais Newsroom, an online resource for members of the media and the investment community. For investor relations inquiries, please contact:. Vice President, Commercial Development. To view Eisai Co., Ltd.s annual report, financial disclosure presentations, and other information, please click here. For media inquiries, please contact:. Jul 31, 2015. Jul 30, 2015.
英才個別学院 - ひとり一人の明日のために - 個別指導塾・学習塾
英才個別学院 - ひとり一人の明日のために - 個別指導塾 学習塾. 個別指導に求められているニーズそれは 生徒一人ひとりに合わせた指導 と 確実な成果 です。 学習成果を上げる為には 生徒のやる気 モチベーション が不可欠だからです。 千葉県船橋市本中山7-8-12 スクエア21 1F 原木中山校が開校します。 東京都練馬区北町2-26-13 ル コンフォール1階 東武練馬校が開校します。
Главная | Eisai Co., Ltd.
Политика использования файлов «cookie. В компании Eisai наша главная забота это пациенты и их семьи, а также повышение эффективности здравоохранения. Мы называем это human health care. Ознакомьтесь с последними выпусками наших корпоративных пресс-релизов и мероприятиями. Ознакомьтесь с нашими всемирными новостями и мероприятиями. Политика в отношении дистрибьюторов. Информация о деятельности Eisai в России и наша коммерческая политика. Соблюдение требований нормативных актов.
DOMAIN ERROR
Eisai AB
SE-182 33 Danderyd, Sweden. Phone: 46 (0)8 501 01 600. Fax: 46 (0)8 501 01 699. For medical information: nordic medinfo@eisai.net. At Eisai we give first thought to patients and their families and to increasing the benefits that health care provides. We call this human health care (hhc).
eisai.us - eisai Resources and Information.